EFFICACY AND SAFETY OF LINZAGOLIX FOR THE TREATMENT OF SEVERE ADENOMYOSIS: FINAL Results FROM A PILOT STUDY

In: Fertility and Sterility · 2021 · vol. 116(3) , pp. e327 · doi:10.1016/j.fertnstert.2021.07.881 · W3199038305
article OA: bronze CC0
AI-generated summary by claude@2026-06, 2026-06-07

This pilot study evaluated the efficacy and safety of linzagolix in treating severe adenomyosis, reporting its final results.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK